Beijing Konruns PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Beijing Konruns PharmaceuticalLtd has a total shareholder equity of CN¥3.5B and total debt of CN¥176.2M, which brings its debt-to-equity ratio to 5.1%. Its total assets and total liabilities are CN¥3.9B and CN¥438.6M respectively. Beijing Konruns PharmaceuticalLtd's EBIT is CN¥164.3M making its interest coverage ratio -39.3. It has cash and short-term investments of CN¥655.8M.
Key information
5.1%
Debt to equity ratio
CN¥176.18m
Debt
Interest coverage ratio | -39.3x |
Cash | CN¥655.84m |
Equity | CN¥3.45b |
Total liabilities | CN¥438.59m |
Total assets | CN¥3.89b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 603590's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥337.8M).
Long Term Liabilities: 603590's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥100.8M).
Debt to Equity History and Analysis
Debt Level: 603590 has more cash than its total debt.
Reducing Debt: 603590's debt to equity ratio has increased from 0% to 5.1% over the past 5 years.
Debt Coverage: 603590's debt is well covered by operating cash flow (130.3%).
Interest Coverage: 603590 earns more interest than it pays, so coverage of interest payments is not a concern.